Quick Answer
IONIS PHARMACEUTICALS INC reported Total Assets of $3.52 billion for the year ending 2025.
- IONIS PHARMACEUTICALS INC showed an increase of +17.3% in Total Assets from 2024 to 2025.
- This data is from IONIS PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $606.35 million | Q3 2010: $575.86 million | Q1 2011: $505.94 million | Q2 2011: $529.57 million | Q3 2011: $505.79 million | Q1 2012: $470.81 million | Q2 2012: $472.39 million | Q3 2012: $485.68 million | Q1 2013: $552.96 million | Q2 2013: $788.65 million | Q3 2013: $881.92 million | Q1 2014: $834.62 million | Q2 2014: $817.78 million | Q3 2014: $793.80 million | Q1 2015: $955.43 million | Q2 2015: $976.26 million | Q3 2015: $988.01 million | Q1 2016: $875.82 million | Q2 2016: $811.11 million | Q3 2016: $843.59 million | Q1 2017: $1.08 billion | Q2 2017: $1.09 billion | Q3 2017: $1.25 billion | Q1 2018: $1.30 billion | Q2 2018: $2.25 billion | Q3 2018: $2.25 billion | Q1 2019: $2.84 billion | Q2 2019: $2.88 billion | Q3 2019: $2.89 billion | Q1 2020: $3.09 billion | Q2 2020: $3.08 billion | Q3 2020: $3.10 billion | Q1 2021: $2.25 billion | Q2 2021: $2.50 billion | Q3 2021: $2.41 billion | Q1 2022: $2.52 billion | Q2 2022: $2.46 billion | Q3 2022: $2.42 billion | Q1 2023: $2.89 billion | Q2 2023: $2.97 billion | Q3 2023: $2.93 billion | Q1 2024: $2.76 billion | Q2 2024: $2.69 billion | Q3 2024: $3.08 billion | Q1 2025: $2.81 billion | Q2 2025: $2.99 billion | Q3 2025: $3.03 billion.
- Over the full 17 years of available data (2009 to 2025), IONIS PHARMACEUTICALS INC's Total Assets has grown by 436.2%.
- Historical annual values: Fiscal year 2025: $3.52 billion | Fiscal year 2024: $3.00 billion | Fiscal year 2023: $2.99 billion | Fiscal year 2022: $2.53 billion | Fiscal year 2021: $2.61 billion | Fiscal year 2020: $2.39 billion | Fiscal year 2019: $3.23 billion | Fiscal year 2018: $2.67 billion | Fiscal year 2017: $1.32 billion | Fiscal year 2016: $912.47 million | Fiscal year 2015: $947.90 million | Fiscal year 2014: $955.81 million | Fiscal year 2013: $847.16 million | Fiscal year 2012: $545.69 million | Fiscal year 2011: $484.89 million | Fiscal year 2010: $550.48 million | Fiscal year 2009: $657.18 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: